Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Another step forward for SELEXive splicing.

Emanuele Buratti1, Francisco E Baralle

  • 1International Centre for Genetic Engineering and Biotechnology, Padriciano 99, Trieste 34012, Italy.

Trends in Molecular Medicine
|January 15, 2005
PubMed
Summary

Researchers identified new splicing elements in SMN exon 7, crucial for understanding spinal muscular atrophy (SMA). This discovery aids in developing RNA molecular medicine to correct aberrant pre-mRNA splicing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TDP-43 Aggregation: The Healthy-Toxic Balance of the Prion-Like Domain.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Functional Activity of TDP 43: A Direct Biomarker for ALS.

medRxiv : the preprint server for health sciences·2026
Same author

Blood-based RNA-Seq of 5412 individuals with rare disease identifies new candidate diagnoses in the National Genomic Research Library.

medRxiv : the preprint server for health sciences·2026
Same author

A novel spliceosomopathy caused by de novo SF3B3 variants.

Genome medicine·2026
Same author

Optineurin Shapes Basal and LPS-Induced Transcriptomes in BV2 Microglia.

International journal of molecular sciences·2025
Same author

Development of [<sup>18</sup>F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology.

Nature communications·2025

Area of Science:

  • Molecular Biology
  • Genetics
  • RNA Splicing

Background:

  • Splicing alterations are increasingly linked to human diseases.
  • Predicting the impact of mutations on splicing is challenging due to limited understanding of cis-acting sequences.
  • Exon recognition is critical for accurate pre-mRNA splicing.

Purpose of the Study:

  • To better define cis-acting sequences that influence exon recognition and splicing.
  • To identify novel splicing-controlling elements within SMN exon 7.
  • To explore potential therapeutic targets for spinal muscular atrophy (SMA) through RNA molecular medicine.

Main Methods:

  • Development of experimental methods integrating pre-mRNA splicing with sequence selection assays.
  • Utilized a novel in vivo selection method employing a partially randomized full-length exon.
  • Focused on identifying splicing elements in SMN exon 7, implicated in SMA.

Main Results:

  • Successfully identified new splicing-controlling elements within SMN exon 7.
  • Demonstrated the efficacy of the novel in vivo selection approach for discovering splicing elements.
  • The identified elements are critical for the proper splicing of SMN exon 7.

Conclusions:

  • The novel in vivo selection method is effective for identifying splicing regulatory elements.
  • New splicing elements in SMN exon 7 have been discovered, advancing our understanding of SMA.
  • This approach holds promise for developing targeted RNA molecular medicine strategies to correct aberrant splicing in diseases like SMA.

Related Experiment Videos